Berman Tabacco
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Berman Tabacco is home to an experienced securities litigation practice group representing a range of clients including public pension funds, government entities, and institutional investors in securities class action cases. The practice group is co-led by experienced litigators Nicole Lavallee, who is based in San Francisco, and specializes in securities fraud and derivative claims, and in the Boston office Leslie Stern is experienced in matters involving federal and state securities law violations. Other key members of the team include San Francisco-based, Daniel Barenbaum and Boston-based Patrick Egan, who focuses on federal securities and antitrust litigation.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- Nicole Lavalee and Daniel Barenbaum are both standout partners in securities litigation. Their quick and detailed analysis in response to client emails and inquiries is exceptional. They are always clear on timelines for deliverables and always provide clients with sufficient time for review of pleadings prior to filing. I am always provided with sufficient updates and copies of filed pleadings; I never have to ask for these.
- The responsiveness of the firm and its partners is remarkable. They are thorough and expert in their legal analysis. They always provide sufficient time for client review prior to the submission of any pleadings.
Key clients
- Alameda County Employees’ Retirement Association
- Plymouth County Retirement Association
Work highlights
Represented Norfolk County Retirement System in Ontario Provincial Council of Carpenters’ Pension Trust Fund v. Walton, C.A. No. 2021-0827 (Del. Ch.), a derivative action seeking to hold Walmart Inc.’s (“Walmart” or the “Company”) controlling shareholders, board of directors and senior management accountable for their alleged breaches of fiduciary duty to Walmart’s shareholders in connection with their decisions relating to, and oversight of, the Company’s opioid distribution and dispensing practices.